Vicarious Surgical (RBOT) Total Current Liabilities (2020 - 2025)
Vicarious Surgical's (RBOT) quarterly Total Current Liabilities came in at $3.9 million in Q4 2025, down 49.08% year-over-year from $7.7 million in Q4 2024, and up 22.92% quarter-over-quarter from $3.2 million in Q3 2025.
Analysis
Vicarious Surgical (RBOT) Total Current Liabilities (2020 - 2025) Analysis & Trends
Vicarious Surgical (RBOT) has reported Total Current Liabilities for 6 consecutive years, with $3.9 million the latest figure, recorded in Q4 2025.
- On a quarterly basis, Total Current Liabilities fell 49.08% year-over-year to $3.9 million in Q4 2025; TTM through Dec 2025 was $3.9 million, a 49.08% decrease from a year earlier, with the FY2025 full-year figure at $3.9 million, down 49.08% from the prior year.
- Total Current Liabilities was $3.9 million for Q4 2025 at Vicarious Surgical, up from $3.2 million in the prior quarter.
- Over five years, Total Current Liabilities peaked at $11.7 million in Q3 2022 and troughed at $1.5 million in Q1 2021.
- A 5-year average of $6.2 million and a median of $6.8 million in 2022 frame the typical range for Total Current Liabilities.
- Across the five-year window, Total Current Liabilities soared 2244.22% in 2021 and tumbled 63.08% in 2025, its largest moves.
- Over 5 years, Total Current Liabilities stood at $6.2 million in 2021, then surged by 34.4% to $8.4 million in 2022, then fell by 13.26% to $7.3 million in 2023, then rose by 5.32% to $7.7 million in 2024, then plunged by 49.08% to $3.9 million in 2025.
- The last three Total Current Liabilities figures came in at $3.9 million (Q4 2025), $3.2 million (Q3 2025), and $5.1 million (Q2 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 17.81 Bn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 1.92 Bn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 11.80 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 6.68 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 6.43 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 1.51 Bn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | 3.17 Bn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 2.36 Bn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 1.28 Bn |
| 10 | Vicarious Surgical | 231,626.35 | -14.81 Mn | - | 3.90 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 3.90 Mn |
| Sep 30, 2025 | 3.18 Mn |
| Jun 30, 2025 | 5.10 Mn |
| Mar 31, 2025 | 7.86 Mn |
| Dec 31, 2024 | 7.67 Mn |
| Sep 30, 2024 | 8.60 Mn |
| Jun 30, 2024 | 7.18 Mn |
| Mar 31, 2024 | 5.08 Mn |
| Dec 31, 2023 | 7.28 Mn |
| Sep 30, 2023 | 7.80 Mn |
| Jun 30, 2023 | 7.49 Mn |
| Mar 31, 2023 | 6.67 Mn |
| Dec 31, 2022 | 8.39 Mn |
| Sep 30, 2022 | 11.68 Mn |
| Jun 30, 2022 | 6.89 Mn |
| Mar 31, 2022 | 6.39 Mn |
| Dec 31, 2021 | 6.25 Mn |
| Sep 30, 2021 | 3.11 Mn |
| Jun 30, 2021 | 2.17 Mn |
| Mar 31, 2021 | 1.51 Mn |